Package Leaflet: Information for the User
Trimbow 87micrograms/5micrograms/9micrograms inhalation solution in a pressurised inhaler
beclometasone dipropionate/formoterol fumarate dihydrate/glycopyrronium
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
Trimbow is a medicine that helps you breathe and contains three active substances:
Beclometasone dipropionate belongs to a group of medicines called corticosteroids, which work by reducing inflammation and irritation in the lungs.
Formoterol and glycopyrronium are medicines called long-acting bronchodilators. They work in different ways to relax the muscles in the airways, helping to widen them and make it easier for you to breathe.
Regular treatment with these three active substances helps to relieve and prevent symptoms such as difficulty breathing, wheezing and coughing in adult patients with chronic obstructive pulmonary disease (COPD).
Trimbow is used for the regular treatment of
Trimbow may reduce the exacerbations (worsening of symptoms) of COPD and asthma symptoms.
COPD is a serious long-term disease where the airways are blocked and the air sacs in the lungs are damaged, making it difficult to breathe.
Asthma is a serious and chronic disease where the muscles around the airways contract (bronchoconstriction) and become swollen and irritated (inflammation). The symptoms come and go and include shortness of breath, wheezing, chest tightness and coughing.
You should use Trimbow every day and not just when you have breathing problems or other asthma symptoms. This will ensure that the medicine controls your asthma properly. Do not use this medicine to relieve a sudden attack of shortness of breath or wheezing.
Do not use Trimbow
If you are allergic to beclometasone dipropionate, formoterol fumarate dihydrate, glycopyrronium or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Trimbow is used as a maintenance treatment for chronic obstructive pulmonary disease. Do not use this medicine to treat a sudden attack of shortness of breath or wheezing.
If your breathing gets worse
If, just after inhaling the medicine, you experience a worsening of shortness of breath or wheezing (breathing with a whistling sound), stop the treatment with the Trimbow inhaler and use your quick-acting "rescue" inhaler immediately. You should contact your doctor right away. Your doctor will assess your symptoms and, if necessary, may change your treatment.
See also section 4. Possible side effects.
If your lung disease worsens
If your symptoms worsen or are difficult to control (e.g., if you are using another "rescue" inhaler more frequently) or if your "rescue" inhaler does not improve your symptoms, go to your doctor immediately. It may be that your lung disease is getting worse and your doctor may need to prescribe a different treatment.
Consult your doctor or pharmacist before you start using Trimbow:
If you are in any of these situations, inform your doctor before you start using Trimbow.
If you have or have had any health problems or allergies or if you are unsure whether you can use Trimbow, consult your doctor or pharmacist before you start using the inhaler.
If you are already using Trimbow
If you are using Trimbow or high doses of other inhaled corticosteroids for long periods of time and you experience a stressful situation (e.g., if you are taken to hospital after an accident, have a severe injury or before an operation), you may need more medicine. In such situations, your doctor may need to increase your dose of corticosteroids to cope with the stress and may prescribe them in the form of tablets or injections.
Contact your doctor if you experience blurred vision or other changes in vision.
Children and adolescents
Do not give this medicine to children and adolescents under 18 years.
Other medicines and Trimbow
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines similar to Trimbow used for your lung disease.
Some medicines may increase the effects of Trimbow, so your doctor will monitor you closely if you are taking these medicines (including some for HIV: ritonavir, cobicistat).
Do not use this medicine with a beta-blocker medicine(used to treat certain heart problems such as angina or to lower blood pressure) unless your doctor has chosen a beta-blocker that does not affect your breathing. Beta-blockers (including beta-blockers in eye drops) may reduce the effects of formoterol or make them disappear completely. On the other hand, the use of other beta2 agonist medicines (which work in the same way as formoterol) may increase the effects of formoterol.
Using Trimbow with:
may cause some changes in the electrocardiogram (ECG, heart tracing). They may also increase the risk of heart rhythm disorders (ventricular arrhythmias).
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
You should only use Trimbow during pregnancy if your doctor advises you to. It is recommended to avoid the use of Trimbow during delivery due to the inhibitory effects of formoterol on uterine contractions.
You should not use Trimbow during breast-feeding. You and your doctor must decide whether to stop breast-feeding or stop the treatment, taking into account the benefit of breast-feeding for your child and the benefit of the treatment for you.
Driving and using machines
It is unlikely that Trimbow will affect your ability to drive and use machines.
Trimbow contains ethanol
Trimbow contains 8.856 mg of alcohol (ethanol) in each actuation, which is equivalent to 17.712 mg per dose of two actuations. The amount in two actuations of this medicine is equivalent to less than 1 ml of wine or beer. The small amount of alcohol in this medicine does not produce any noticeable effects.
Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Adults
The recommended dose is two doses in the morning and two doses at night.
Do not use more than the amount indicated by your doctor.
You should use Trimbow every day, even when your asthma is not causing problems.
Do not use this medication to relieve a sudden attack of breathing difficulties or wheezing.
If you think the medication is not working very well, consult your doctor.
If you have been using another inhaler that contained beclometasone dipropionate previously, consult your doctor, as the effective dose of beclometasone dipropionate in Trimbow for the treatment of chronic obstructive pulmonary disease may be lower than that of other inhalers.
Route of administration
Trimbow is for inhalation use only.
You should inhale the medication through the mouth, which carries the medication directly to the lungs.
This medication is in a pressurized container inside a plastic inhaler with a mouthpiece.
Trimbow is available in three package sizes:
If you have been prescribed a package that provides 60doses or 120doses
There is a counter on the back of the inhaler, which indicates how many doses are left. Each time you press the pressurized container, a dose of medication will be released and the counter will subtract one unit. Avoid dropping the inhaler, as this could cause the counter to decrement.
If you have been prescribed a package that provides 180doses
There is an indicator on the back of the inhaler, which indicates how many doses are left. Each time you press the pressurized container, a dose of medication will be released and the counter will turn slightly. The number of remaining doses is displayed in intervals of 20. Avoid dropping the inhaler, as this could cause the counter to decrement.
Checking the inhaler
Before using the inhaler for the first time, you should check it in the following way to ensure it is working properly.
60
| 120
| 180
|
How to use the inhaler
Stand or sit upright to perform the inhalation.
IMPORTANT: do not perform steps 2 to 5 too quickly.
To take the second dose, hold the inhaler upright for about half a minute and then repeat steps 2 to 5.
If some of the gas escapes from the top of the inhaler or from the corner of your lips, it means that Trimbow will not reach your lungs as it should. Take another dose following the instructions starting again from step 2.
After use, replace the protective cap.
To avoid a fungal infection in the mouth and throat, rinse your mouth or gargle with water without swallowing it or brush your teeth after each use of the inhaler.
When to get a new inhaler
You should get a replacement when the counter or indicator shows the number 20. Stop using the inhaler when the counter or indicator shows a 0, as any remaining medication in the inhaler may be insufficient to provide a complete dose.
If you have weakness to grasp, you may find it easier to hold the inhaler with both hands: place your two index fingers on the top of the inhaler and your two thumbs on the bottom of the inhaler.
If you find it difficult to use the inhaler while starting to inhale, you can use the AeroChamber Plus spacer device. Consult your doctor or pharmacist about this device.
It is essential that you read the leaflet provided with the AeroChamber Plus spacer device and follow its instructions for use and cleaning carefully.
Cleaning the Trimbow inhaler
You should clean the inhaler once a week.
If you use more Trimbow than you should
It is essential that you take the dose as indicated by your doctor. Do not exceed the prescribed dose without consulting your doctor first.
If you use more Trimbow than you should, the adverse effects described in section 4 may appear.
Tell your doctor if you have used more Trimbow than you should and if you experience any of these symptoms. Your doctor may want to perform some blood tests.
If you forget to use Trimbow
Use it as soon as you remember. If it is almost time for the next dose, do not take the missed dose, but only the next dose at the correct time. Do not double the dose.
If you stop treatment with Trimbow
It is essential to use Trimbow every day. Do not stop treatment with Trimbow or reduce the dose, even if you feel better or do not have symptoms. If you want to do this, consult your doctor.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
There is a risk of worsening breathing difficulties and wheezing immediately after using Trimbow, known as paradoxical bronchospasm (may affect up to 1 in 1,000 people). If this happens, you should stop treatment with Trimbow and use your quick-acting "rescue" inhaler immediately to treat breathing difficulties and wheezing. You should contact your doctor immediately.
Tell your doctor immediately
Tell your doctor if you notice any of the following symptoms during the use of Trimbow, as they may be due to a lung infection (may affect up to 1 in 10 people):
Possible side effects are listed below by frequency.
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
|
|
Rare(may affect up to 1 in 1,000 people)
|
|
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(cannot be estimated from the available data)
The use of inhaled corticosteroids in high doses for a prolonged period may cause, in very rare cases, effects on the body:
Trimbow does not contain a high-dose inhaled corticosteroid, but your doctor may want to check your cortisol levels in your blood from time to time.
The following side effects may also occur when inhaled corticosteroids are used in high doses for a prolonged period, but their frequency is not currently known (cannot be estimated from the available data):
These effects are more likely in children.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System for Human Use https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date stated on the label and carton after CAD / EXP. The expiration date is the last day of the month indicated.
Do not freeze.
Do not expose to temperatures above 50°C.
Do not puncture the pressurized container.
Before dispensing:
Store in a refrigerator (between 2°C and 8°C).
After dispensing (after receiving this medication from your pharmacist):
Pressurized container of 60 puffs: | Store the inhaler below 25°C for a maximum of 2 months. |
Pressurized container of 120 (taken from a single or multiple package) and 180 puffs: | Store the inhaler below 25°C for a maximum of 4 months. |
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Trimbow Composition
The active ingredients are: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium.
Each delivered dose (the dose that comes out of the mouthpiece) contains 87 micrograms of beclometasone dipropionate, 5 micrograms of formoterol fumarate dihydrate, and 9 micrograms of glycopyrronium (in the form of 11 micrograms of glycopyrronium bromide).
Each measured dose (the dose that comes out of the valve) contains 100 micrograms of beclometasone dipropionate, 6 micrograms of formoterol fumarate dihydrate, and 10 micrograms of glycopyrronium (in the form of 12.5 micrograms of glycopyrronium bromide).
The other ingredients are: anhydrous ethanol (see section 2), hydrochloric acid, propellant: norflurane.
This medication contains fluorinated greenhouse gases.
Each 60-puff inhaler contains 6.481 g of norflurane (HFC-134a) which corresponds to 0.009 tons of CO2 equivalent (global warming potential GWP = 1430).
Each 120-puff inhaler contains 10.37 g of norflurane (HFC-134a) which corresponds to 0.015 tons of CO2 equivalent (global warming potential GWP = 1430).
Each 180-puff inhaler contains 14.259 g of norflurane (HFC-134a) which corresponds to 0.02 tons of CO2 equivalent (global warming potential GWP = 1430).
Product Appearance and Package Contents
Trimbow is an inhalation solution in a pressurized container.
Trimbow is presented in a pressurized container (aluminum-coated), with a metered-dose valve. The pressurized container is inserted into a plastic inhaler. This incorporates a mouthpiece with a plastic protective cap and a dose counter (containers with 60 and 120 doses) or a dose indicator (containers with 180 doses).
Each container contains a pressurized container that provides 60 doses, 120 doses, or 180 doses. Additionally, there are multiple containers that contain 240 doses (2 pressurized containers with 120 doses each) or 360 doses (3 pressurized containers with 120 doses each).
Only some package sizes may be marketed.
Marketing Authorization Holder
Chiesi Farmaceutici S.p.A.
Via Palermo 26/A
43122 Parma
Italy
Manufacturer
Chiesi Farmaceutici S.p.A.
Via San Leonardo 96
43122 Parma
Italy
Chiesi SAS
2 rue des Docteurs Alberto et Paolo Chiesi
41260 La Chaussée Saint Victor
France
Chiesi Pharmaceuticals GmbH
Gonzagagasse 16/16
1010 Wien
Austria
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Belgium Chiesi sa/nv Tel: + 32 (0)2 788 42 00 | Lithuania Chiesi Pharmaceuticals GmbH Tel: + 43 1 4073919 |
Luxembourg Chiesi sa/nv Tel: + 32 (0)2 788 42 00 | |
Czech Republic Chiesi CZ s.r.o. Tel: + 420 261221745 | Hungary Chiesi Hungary Kft. Tel.: + 36-1-429 1060 |
Denmark Chiesi Pharma AB Tlf: + 46 8 753 35 20 | Malta Chiesi Farmaceutici S.p.A. Tel: + 39 0521 2791 |
Germany Chiesi GmbH Tel: + 49 40 89724-0 | Netherlands Chiesi Pharmaceuticals B.V. Tel: + 31 88 501 64 00 |
Estonia Chiesi Pharmaceuticals GmbH Tel: + 43 1 4073919 | Norway Chiesi Pharma AB Tlf: + 46 8 753 35 20 |
Greece Chiesi Hellas AEBE Τηλ: + 30 210 6179763 | Austria Chiesi Pharmaceuticals GmbH Tel: + 43 1 4073919 |
Spain Chiesi España, S.A.U. Tel: + 34 93 494 8000 | Poland Chiesi Poland Sp. z.o.o. Tel.: + 48 22 620 1421 |
France Chiesi S.A.S. Tél: + 33 1 47688899 | Portugal Tecnifar- Indústria Técnica Farmacêutica S.A. Tel.: +351 210330700 |
Croatia Chiesi Pharmaceuticals GmbH Tel: + 43 1 4073919 | Romania Chiesi Romania S.R.L. Tel: + 40 212023642 |
Ireland Chiesi Farmaceutici S.p.A. Tel: + 39 0521 2791 | Slovenia Chiesi Slovenija d.o.o. Tel: + 386-1-43 00 901 |
Iceland Chiesi Pharma AB Sími: +46 8 753 35 20 | Slovakia Chiesi Slovakia s.r.o. Tel: + 421 259300060 |
Italy Chiesi Italia S.p.A. Tel: + 39 0521 2791 | Finland Chiesi Pharma AB Puh/Tel: +46 8 753 35 20 |
Cyprus Chiesi Farmaceutici S.p.A. Τηλ: + 39 0521 2791 | Sweden Chiesi Pharma AB Tel: +46 8 753 35 20 |
Latvia Chiesi Pharmaceuticals GmbH Tel: + 43 1 4073919 |
Date of Last Revision of this Leaflet: November 2024
Other Sources of Information
Detailed information on this medication is available on the European Medicines Agency website: http://www.ema.europa.eu.
The average price of TRIMBOW 87/5/9 micrograms solution for inhalation in a pressurized container in October, 2025 is around 74.35 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.